Related Experiment Video
Updated: May 6, 2026
10:45
Organotypic Collagen I Assay: A Malleable Platform to Assess Cell Behaviour in a 3-Dimensional Context
Published on: October 13, 2011
22.5K
Tamoxifen Upregulates Collagenase Gene Expression in Human Dermal Fibroblasts
1From the Departments of Surgery, Medicine, and Integrated Biosciences, The University of Chicago, Chicago, Ill.
Plastic and Reconstructive Surgery. Global Open
|February 13, 2024
Summary
Tamoxifen alters fibroblast shape and increases collagenase synthesis, potentially reducing scar formation by inhibiting protein kinase C (PKC) activity. This suggests tamoxifen as a promising agent for treating fibrosis.
Area of Science:
- Cell Biology
- Dermatology
- Pharmacology
Background:
- Tamoxifen inhibits transforming growth factor beta (TGF-β) and wound scarring.
- It acts as an estrogen antagonist and protein kinase C (PKC) inhibitor.
- PKC inhibition leads to cytoskeletal changes, cell detachment, and increased collagenase synthesis.
Purpose of the Study:
- To investigate tamoxifen's effects on human foreskin fibroblasts.
- To determine if tamoxifen alters cytoskeletal organization, cell shape, and collagenase synthesis.
- To compare tamoxifen's effects to known PKC/calmodulin inhibitors like H-7.
Main Methods:
- Human dermal fibroblasts were treated with tamoxifen and H-7.
- Effects on cell morphology, cytoskeletal organization, and collagenase gene expression were analyzed.
- Fibroblast-populated collagen matrices were used to measure hydroxyproline release.
Main Results:
- Tamoxifen induced actin filament depolymerization and cell rounding (spindle to spheroidal shape).
- Both tamoxifen and H-7 increased collagenase synthesis compared to controls.
- A 23% increase in hydroxyproline release was observed in tamoxifen-treated matrices.
Conclusions:
- Tamoxifen may reduce scarring by inhibiting fibroblast PKC activity.
- This inhibition down-regulates pro-fibrotic TGF-β signaling and upregulates collagenase.
- Tamoxifen and analogues show promise for regulating fibrosis and scarring disorders.
